PI Industries Ltd — earnings calls
1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.
Q1 FY27 — transcript filed; not yet summarisedQ4 FY26
Q4 FY26 earnings call
PI Industries reported consolidated FY26 revenue of Rs 67,137 million with EBITDA margins of 25% and a cash balance of Rs 34,265 million, while Q4 FY26 revenue was Rs 15,652 million, showing sequential growth. Management said the pharma business grew 40% for the full year and that new products contributed 18% of AgChem exports, while domestic agrochemical demand remained impacted by channel inventory, pricing pressure and lower crop acreages. Management said it expects growth in FY27 supported by export recovery, new product launches including the NCE Pioxaniliprole, and continued scale-up of pharma and biologicals.